What is the typical amount of blood loss during a cesarean section?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Blood Loss During Cesarean Section

The typical blood loss during a cesarean section is approximately 500-600 mL, with abnormal bleeding defined as >1000 mL. 1

Expected Blood Loss Ranges

Standard Cesarean Delivery

  • Median blood loss: 400-600 mL 2, 3
  • Mean blood loss: 557-792 mL depending on indication 4, 2
  • 95th percentile: 1300 mL 2

The AAGBI guidelines establish that abnormal bleeding requiring immediate senior clinician response occurs when blood loss exceeds 1000 mL after cesarean delivery 1. This threshold is double that of vaginal delivery (>500 mL), reflecting the inherently higher blood loss associated with surgical delivery.

Blood Loss by Indication

Recent research demonstrates clinically significant variation based on surgical indication 4:

  • Elective cesarean: Lowest blood loss, with only 1-2% exceeding 1500 mL
  • Labor arrest: Highest blood loss among routine indications (mean 1065 mL for primary cesarean), with 18% of primary and 13% of repeat cesareans exceeding 1500 mL
  • Placenta accreta with hysterectomy: Mean 1442 mL
  • Repeat elective cesarean: Mean 697 mL

This variation matters clinically: The difference between elective and labor arrest cesareans represents a 10-fold increase in risk of severe hemorrhage (>1500 mL), despite similar mean values suggesting the presence of frequent large outliers 4.

Measurement Accuracy Considerations

Direct measurement of blood loss during cesarean is notoriously difficult 1. Current methods have significant limitations:

  • Visual estimation: Consistently underestimates actual blood loss 5
  • Quantitative measurement (weighing sponges, suction canisters): More accurate but still underestimates compared to calculated blood loss based on hemoglobin changes 5
  • Both methods show low sensitivity and negative predictive values for detecting postpartum hemorrhage 5

Clinical implication: Every effort should be made to directly measure blood loss by weighing blood-soaked materials and using graduated suction canisters, as this correlates better with hemoglobin decline and improves outcomes 1.

Coagulation Impact

Even moderate blood loss (mean 506 mL) during cesarean section produces measurable prothrombotic changes 3:

  • 14.8% decrease in protein S immediately post-surgery
  • 37% increase in activated protein C resistance
  • These changes aggravate pregnancy-induced hypercoagulability and contribute to increased thrombosis risk in early puerperium

Clinical Response Thresholds

Immediate senior team response required when blood loss exceeds 1000 mL 1:

  • Obstetrician, anesthetist, and senior midwife must attend
  • Obtain full blood count, coagulation studies, group and screen
  • Venous blood gas for rapid hemoglobin and lactate (>2 mmol/L indicates shock)
  • Activate cell salvage if not already in use
  • Administer tranexamic acid 1g IV if not already given 1, 6

The WHO strongly recommends early tranexamic acid (within 3 hours of birth) for all clinically diagnosed postpartum hemorrhage, including blood loss >1000 mL after cesarean, regardless of etiology 6.

Risk Stratification for Blood Preparation

The indication for cesarean delivery should guide preoperative blood preparation, not simply the "average" expected loss 4:

  • Elective cesarean: Minimal preparation needed (1-2% risk of >1500 mL loss)
  • Labor arrest: Substantial preparation warranted (13-18% risk of >1500 mL loss)
  • Placenta accreta: Aggressive preparation essential

This approach recognizes that statistical means obscure the presence of frequent large outliers in certain indications, which cannot be predicted by average blood loss estimates alone 4.

Related Questions

Should an asymptomatic urine culture with 10,000–49,000 CFU/mL Escherichia coli be treated?
What is the minimum recommended duration of antimicrobial therapy for a deep puncture wound?
A 10‑day postpartum woman presents with dysuria and a urine culture growing mixed microbiota >100,000 CFU/mL; how should this be managed?
What is the appropriate 10‑day antibiotic regimen for a patient undergoing ENT follow‑up after image‑guided fine‑needle aspiration/biopsy, assuming no documented β‑lactam allergy?
In a 56-year-old male with persistent testicular pain and a normal scrotal ultrasound, would a spermatic cord block be beneficial, and what outcomes and follow‑up treatment should be expected if the block improves his pain?
Can catatonia occur in a recurrent or cyclic pattern?
What does it mean that my electrodiagnostic study shows mild bilateral median mononeuropathies (carpal tunnel syndrome) with no evidence of axonal loss, denervation of the abductor pollicis brevis muscles, cervical radiculopathy, ulnar mononeuropathy, or peripheral polyneuropathy?
What is the appropriate diagnosis and treatment plan for a young adult female who presented after an intentional overdose of hydroxyzine and sertraline, with a history of borderline personality disorder, major depressive disorder, generalized anxiety disorder, recent daily alcohol and THC use, and who is currently agitated, refusing food, and non‑participatory?
Does finasteride cause decreased libido in women, and how should it be managed?
Should a patient on oral iron supplementation discontinue therapy when hemoglobin and hematocrit are at the upper limit of normal but serum ferritin remains low?
Is the LOCOA (esflurbiprofen) 40 mg transdermal patch appropriate for adult patients with osteoarthritis‑related joint pain?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.